April 2, 2026 — Omron Healthcare Co. has launched a randomized controlled trial in collaboration with the University of California, San Francisco (UCSF) to evaluate a new model for the early detection ...
Hypertension
This page includes news and new technology on hypertension. The condition is caused by abnormally high blood pressure that causes excess force and pressure of the blood against the artery walls. Long-term, this can cause damage the vessels and contributes to heart disease. Therapies include antihypertensive medications such as diurestics and renal denervation therapy.
-
-
Jan. 16, 2026 — MemorialCare Heart & Vascular Institute has launched the FDA-approved Symplicity Renal Denervation (RDN) procedure, a minimally invasive treatment now available at Long Beach Medical ...
-
Oct. 30, 2025 — Recor Medical and its parent company, Otsuka Medical Devices presented the results from two clinical studies presented at the recent 2025 Transcatheter Cardiovascular Therapeutics (TCT ...
-
Hypertension remains the leading modifiable driver of cardiovascular disease and premature death.1 Even with multiple drug classes available, nearly 70% of adults have uncontrolled blood pressure.2 ...
April 2, 2026 — Omron Healthcare Co. has launched a randomized controlled trial in collaboration with the University of ...
April 03, 2026
March 28, 2026-- At ACC.26, Corcept Therapeutics Inc. presented late-breaking data from its MOMENTUM trial examining the ...
April 02, 2026
March 28, 2026 — Medtronic has announced the EMBRACE trial, led by Dr. Roxana Mehran, Professor of Medicine and Director ...
March 31, 2026
Jan. 16, 2026 — MemorialCare Heart & Vascular Institute has launched the FDA-approved Symplicity Renal Denervation (RDN) ...
January 19, 2026
Oct. 30, 2025 — Recor Medical and its parent company, Otsuka Medical Devices presented the results from two clinical ...
November 03, 2025
Feature | Renal Denervation | Kyle Hardner
Hypertension remains the leading modifiable driver of cardiovascular disease and premature death.1 Even with multiple ...
October 02, 2025
Sept. 04, 2025 — CorVista Health has published a new case series in the Journal of the American College of Cardiology ...
September 09, 2025
Sept. 5, 2025 — Idorsia Ltd has announced a first-of-its-kind initiative with the Stanford Hypertension Center and Duke ...
September 08, 2025
Aug. 19, 2025 — Idorsia Ltd recently announced its novel dual endothelin receptor antagonist (ERA), Tryvio (aprocitentan ...
August 27, 2025
July 7, 2025 — Medtronic announced that it has treated the first patient in its SPYRAL GEMINI Pilot program (including ...
July 07, 2025
May 19, 2025 — Gradient Denervation Technologies recently announced the company’s pulmonary denervation system has ...
May 20, 2025
April 9, 2025 — Idorsia Ltd recently announced that the US Food & Drug Administration (FDA), after having released ...
April 09, 2025
Mar. 10, 2025-- Corcept Therapeutics Inc., a commercial-stage company engaged in the discovery and development of ...
March 11, 2025
At the Cardiovascular Research Technologies (CRT) 2025 conference in Washington, D.C., Medtronic presented new data and ...
March 10, 2025
Jan. 13, 2025 — Medtronic recently announced that the Centers for Medicare & Medicaid Services (CMS) is opening a ...
January 27, 2025